Perrigo Company

Perrigo Company plc is a prominent global healthcare supplier that specializes in developing, manufacturing, and distributing over-the-counter (OTC) and prescription pharmaceuticals, nutritional products, and active pharmaceutical ingredients. The company is recognized as the largest manufacturer of OTC pharmaceutical products for the store brand market and has established itself as a leader in pharmaceutical technologies. Since 2018, Perrigo has focused exclusively on consumer self-care after divesting its animal health and generic pharmaceuticals businesses. In North America, which accounts for two-thirds of its total sales, Perrigo's product offerings are primarily private-label consumer health goods sold to major retailers such as Walmart, Amazon, Costco, and CVS. Additionally, Perrigo operates in Europe, Australia, and parts of Asia, generating revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

Roberto Khoury

Executive Vice President and President of CSCI

Ron Winowiecki

CFO

18 past transactions

Ranir

Acquisition in 2019
Ranir is a global leader in oral and personal healthcare products, they provide store brand and contract manufacturing services to their partners. Through trust, teamwork and a commitment to delivering best-in-class products, they enjoy valued, long-standing relationships with most of the major retailers throughout the world. From concept to shelf, their dedicated research, development and manufacturing groups work in tandem with their customers every step of the way. The end result: a sustainable competitive advantage that helps their customers win with their consumers.

Laboratoire de la Mer

Acquisition in 2016
Laboratoire de la Mer SAS is a pharmaceutical company based in Saint-Malo, France, specializing in the development and marketing of health and personal care products. The company offers a range of products including nasal congestion relief, ear cleansing washes for excess ear wax, and oral and dental care solutions aimed at older individuals and those with sore or receding gums. Additionally, Laboratoire de la Mer provides dietary supplements and has a focus on utilizing marine-based ingredients, particularly seaweed, in its formulations. The efficacy and tolerance of these products have been validated through clinical studies.

Geiss, Destin & Dunn

Acquisition in 2016
Geiss, Destin & Dunn is a small national distributor of over-the-counter healthcare and consumer goods products.

ScarAway

Acquisition in 2015
ScarAway's proven Advanced Silicone Technology has been shown in countless clinical studies to reduce the appearance of scars, new and old. This innovative technology simulates the natural barrier function of healthy skin, hydrating scar tissue to soften the scar, shrinking, flattening and fading it. Used after surgery or injury, our advanced technology helps treat and prevent abnormal scar formation. ScarAway helps alleviate the itching and discomfort associated with scars.

Omega Pharma

Acquisition in 2014
Omega Pharma engages in the development and sale of prescription-free health and personal care products to pharmacies and other medical sectors together with its subsidiaries. It offers personal care products for face and body, sun care products, and baby-specific products under the Bodysol/Galenco, ACO, Lactacyd, Claire Fisher, Bergasol, and Biodermal brand names; and medicated skin care products for various skin conditions and allergies under the Dermalex, Septivon, and Wartner brands. Omega Pharma also provides cough and cold products, and allergy products, as well as aromatherapy and homeopathic solutions under the Bittner/Aflubin, Prevalin/Beconase, Physiomer/Libenar, and Phytosun brand names; and anti-parasites under the Paranix and Jungle Formula brands for human, as well as Paravet/Clément-Thékan brand name for pets. In addition, it offers vitamins, minerals, supplements, and natural remedies under the Davitamon, Biover, Abtei, Granufunk and Bional brand names; weight management products under the XLS and XLS Medical brands; pregnancy tests and self-diagnostic products under the Predictor brand name; pain relief products under the Solpadeine and Optalidon brands; eye care products under the Opticalm(ax) brand; and sleep aid products under the brand names of Silence and Nytol. Omega Pharma primarily operates in Europe, Turkey, Australia, Argentina, and South-Africa. Marc Coucke and Yvan Vindevogel founded it in 1987. Omega Pharma has its headquarters in Nazareth in Belgium. It operates as a subsidiary of Perrigo Company.

Elan

Acquisition in 2013
Elan Corporation, plc is a biotechnology company headquartered in Ireland, established in December 1969 and transitioning to a public limited company in January 1984. The company focuses on addressing significant unmet medical needs through innovations in science, particularly in the fields of neurodegenerative and autoimmune diseases. Elan operates two main business units: BioNeurology, which develops treatments for conditions such as Alzheimer's and Parkinson's diseases, and Elan Drug Technologies, which specializes in the manufacturing of innovative pharmaceuticals. Through its dedicated efforts, Elan aims to improve the lives of patients and their families by delivering effective therapeutic solutions.

Fera Pharmaceuticals

Acquisition in 2013
Fera Pharmaceuticals is a Biotechnology company.

Rosemont Pharmaceuticals

Acquisition in 2013
Rosemont Pharmaceuticals Limited is a manufacturer and supplier of liquid medicines, catering primarily to patients with swallowing difficulties. Established in 1967 and based in Leeds, United Kingdom, the company provides a diverse range of products that include formulations for anesthesia, cardiovascular, central nervous, endocrine, gastrointestinal, infectious diseases, malignant conditions, immunosuppression, musculoskeletal and joint diseases, as well as nutrition, respiratory issues, and various disorders related to obstetrics, gynecology, and the urinary tract. Rosemont Pharmaceuticals serves healthcare professionals and patients globally, facilitating access to its products through online sales. The company was formerly known as R.P. Drugs Limited before rebranding in 1994.

Velcera

Acquisition in 2013
Velcera is a specialty pharmaceutical company with a passion for assuring pets receive the medicines they need to support excellent overall health. At Velcera, they are dedicated to developing innovative, high-quality products for the pet health market. They comply with the highest standards of practice through all phases, from development to manufacturing to marketing.

Paddock Laboratories

Acquisition in 2011
Paddock Laboratories provides pharmaceutical manufacturer of generic Rx pharmaceuticals and OTC specialty products.

PBM Products

Acquisition in 2010
PBM Products is specializes in manufacturing, distributing, and marketing consumer food, nutritional, and pharmaceutical products.

ORION Laboratories

Acquisition in 2010
ORION Laboratories manufactures and markets therapeutic pharmaceuticals. It specializes in cream and liquid fills.

Laboratorios Diba

Acquisition in 2008
Laboratorios Diba is a store brand manufacturer of over-the-counter (OTC) and prescription pharmaceuticals, including antibiotics, hormonals and opthalmics.

JB Laboratories

Acquisition in 2008
JB Laboratories is a contract manufacturer of OTC and nutrition products for leading healthcare suppliers in the U.S.
Brunel Healthcare are the UK's leading manufacturer of vitamins, minerals and nutritional supplements. We specialise in private label and contract manufacture of shelf ready goods for the global marketplace. Our long standing base of private label customers includes some of the world's largest retailers, from whom we have won many awards. We also manufacture and pack many internationally recognised brands. We were proud recipients of the Queen’s Award for Enterprise in 2015. This is one of the most prestigious accolades that a British business can receive. We operate from a modern, purpose built 30,000m2 development and production facility in Derbyshire, Central England. Sector leading quality standards have been paramount to driving our continued growth. Licensed by the MHRA, we operate to cGMP standards.

Galpharm International

Acquisition in 2008
Galpharm International engages in the manufacture and distribution of healthcare remedies in the United Kingdom.

Agis Industries

Acquisition in 2005
Agis Industries is a developer and manufacturer of specialized generic pharmaceuticals and active pharmaceutical ingredients.

Wrafton Laboratories

Acquisition in 2001
Wrafton Laboratories is a supplier of store brand products to major grocery and pharmacy retailers in the U.K. and is a contract manufacturer of over-the-counter (OTC) pharmaceuticals.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.